Modern understanding of adult celiac disease
https://doi.org/10.31146/1682-8658-ecg-188-4-84-95
Abstract
The article presents a modern view of celiac disease within the framework of the classification concept of gluten- associated disorders. The prevalence of the disease, the modern model of the etiopathogenesis of celiac disease, clinical manifestations, and the possibilities of differential diagnosis are discussed. According to the European guidelines, a strategy for monitoring outpatients with celiac disease is presented, based on baseline characteristics of the disease, regular doctor- patient interaction, and prevention of gluten- associated disorders.
About the Authors
L. S. Oreshko
North- Western State Medical University named after I. I. Mechnikov, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Ludmila S. Оrеshkо, MD, professor of the Department of Internal Medicine Propedeutics, Gastroenterology and Dietetics n. a. S. M. Ryss
191015, Kirochnay street, 41, Saint- Petersburg
Scopus ID: 24081182800
I. G. Bakulin
North- Western State Medical University named after I. I. Mechnikov, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Igor G. Bakulin, doctor of Medical Sciences, Professor, Head of the Department of Internal Medicine Propedeutics, Gastroenterology and Dietetics n. a. S. M. Ryss
191015, Kirochnay street, 41, Saint- Petersburg
E. B. Avalueva
North- Western State Medical University named after I. I. Mechnikov, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Elena B. Avalueva, doctor of Medical Sciences, Professor of the Department of Internal Medicine Propedeutics, Gastroenterology and Dietetics n. a. S. M. Ryss
191015, Kirochnay street, 41, Saint- Petersburg
E. A. Semenova
North- Western State Medical University named after I. I. Mechnikov, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Elena A. Semenova, candidate of medical sciences, assistant of the Department of Internal Medicine Propedeutics, Gastroenterology and Dietetics n. a. S. M. Ryss
191015, Kirochnay street, 41, Saint- Petersburg
Scopus ID: 56677811200
S. I. Sitkin
North- Western State Medical University named after I. I. Mechnikov, Ministry of Health of Russian Federation;
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Stanislav I. Sitkin, Doctor of Medicine, Associate Professor of the Department of Internal Medicine Propedeutics, Gastroenterology and Dietetics n. a. S. M. Ryss; Head of the Epigenetics & Metagenomics Research Group of the Institute of Perinatology and Pediatrics
191015, Kirochnay street, 41, Saint- Petersburg,
Akkuratova St., 2, St. Petersburg 197341
References
1. Volta U, Caio G, Stanghellini V, De Giorgio R. The changing clinical profile of celiac disease: a 15-year experience (1998–2012) in an Italian referral center. BMC Gastroenterol. 2014 Nov 18;14:194. doi: 10.1186/s12876–014–0194-x. PMID: 25404189; PMCID: PMC4236812.
2. Volta U., Caio G, Tovoli F. et al. Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness. Cell Mol Immunol. 2013 10, 383–392. Doi: 10.1038/cmi.2013.28
3. De Lorgeril M., Salen P. Gluten and wheat intolerance today: are modern wheat strains involved? International Journal of Food Sciences and Nutrition. 2014 65:5, 577– 581. DOI: 10.3109/09637486.2014.886185
4. Parfenov A. I., Maev I. G., Baranov A. A. et al. [AllRussian Consensus on the Diagnosis and Treatment of Celiac Disease in Children and Adults * Adopted at the 42nd Scientifi c Session of the Central Scientifi c Research Institute of Geology]. Pediatrics is an appendix to the Consilium Medicum magazine. 2016; 1: 6–19. (In Russ.)
5. Al- Toma A, Volta U, Auricchio R. et al. United European Gastroenterology Journal, 13 Apr 2019, 7(5):583–613. DOI: 10.1177/2050640619844125 PMID: 31210940 PMCID: PMC6545713.
6. Sapone, A., Bai, J.C., Ciacci, C. et al. Spectrum of glutenrelated disorders: consensus on new nomenclature and classification. BMC Med. 10, 13 (2012). Doi: 10.1186/1741–7015–10–13
7. Oxentenko А. S., Rubio- Tapia A. Celiac Disease. Mayo Clinic Proceedings. 2019 December 94;12, 2556–2571. DOI: 10.1016/j.mayocp.2019.02.019
8. Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol. 2012;107(8): 1248–55. DOI: 10.1038/ajg.2012.130
9. Jansson- Knodell, C. L., Hujoel, I. A., West, C. P., Taneja, V., Prokop, L. J., Rubio- Tapia, A., & Murray, J. A. (2019). Sex Difference in Celiac Disease in Undiagnosed Populations: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 17(10), 1954– 1968.e13. Doi: 10.1016/j.cgh.2018.11.013
10. King JA, Jeong J, Underwood FE, et al. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis. Th e American Journal of Gastroenterology. 2020 Apr;115(4):507–525. DOI: 10.14309/ajg.0000000000000523.
11. Mustalahti K, Catassi C, Reunanen A, et al.; Coeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42(8):587–95. doi: 10.3109/07853890.2010.505931. Fasano A., Catassi C. Celiac disease. A. Fasano, C. Catassi. N Engl J Med. 2012, Vol. 367, pp. 2419–26.
12. Jelínková, Lenka, Tučková, Ludmila, Cinová, Jana, Flegelová, Zuzana and Tlaska lová- Hogenová, Helena(2004), Gliadin stimulates human monocytes to production of IL-8 and TNF-α through a mechanism involving NF-κB, FEBS Letters, 571, doi: 10.1016/j.febslet.2004.06.057
13. Lammers, K.M., Khandelwal, S., Chaudhry, F., Kryszak, D., Puppa, E.L., Casolaro, V. and Fasano, A. (2011), Identification of a novel immunomodulatory gliadin peptide that causes interleukin‐8 release in a chemokine receptor CXCR3‐dependent manner only in patients with coeliac disease. Immunology, 132: 432–440. Doi: 10.1111/j.1365–2567.2010.03378.x
14. Silano M, Vincentini O, De Vincenzi M. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease. Curr Med Chem. 2009;16(12): 1489–1498.
15. Oreshko L.S. [Historical and clinical aspects of celiac disease: monograph]. SPb.: SPbGMA them. I. I. Mechnikova, 2010. 120 p. (In Russ.)
16. Pagliari D., Urgesi R., Frosali S., et al. The interaction among microbiota, immunity, and genetic and dietary factors is the condicio sine qua non celiac disease can develop. J Immunol Res. 2015;2:1–10. DOI:10.1155/2015/123653
17. Rostami- Nejad M., Romanos J., Rostami K., Ganji A., et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World J Gastroenterol. 2014; 20(20): 6302–8.
18. Spurkland A., Sollid L. M., Polanco I., Vartdal F., Th orsby E. Hla-dr and -dq genotypes of celiac disease patients serologically typed to be non-dr3 or non-dr5/7. Hum Immunol. 1992; 35:188–192. DOI: 10.1016/0198–8859(92)90104-u
19. Catassi C., Fasano A. Celiac disease. Current opinion in Gastroenterology. 2008;24: 687–691. DOI:10.1097/MOG.0b013e32830edc1e
20. Brown N.K., Guandalini S., Semrad C., Kupfer S. S. A Clinician’s Guide to Celiac Disease HLA Genetics. A Am J Gastroenterol. 2019;114(10):1587–1592. DOI: 10.14309/ajg.0000000000000310
21. Holopainen P., Mustalahti K., Uimari P., et al. Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut. 2001;48:696–701. DOI:10.1136/gut.48.5.696
22. Evaluation of cytokine polymorphisms (TNFalpha, IFNgamma and IL-10) in Down patients with coeliac disease. Dig Liver Dis. Dec. 2005; 37(12):923–927. DOI:10.1016/j.dld.2005.08.001
23. Lázár- Molnár E., Snyder M. The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics. Clin Lab Med. 2018;38(4):655–668. DOI: 10.1016/j.cll.2018.07.007
24. Karell K., Louka A. S., Moodie S. J. et al. European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum.Immunol. 2003;64:469– 477. DOI:10.1016/S0198–8859(03)00027–2
25. Verdu E.F., Galipeau H. J., Jabri B. Novel players in celiac disease pathogenesis: the role of gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;185:2969–82. DOI:10.1038/nrgastro.2015.90
26. Sellitto M., Bai G., Serena G., et al. Proof of concept of microbiomemetabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012;7: e33387. DOI:10.1371/journal.pone.0033387
27. Olivares M., Neef A., Castillejo G., et al. The HLADQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut. 2015;64:406–417. DOI:10.1136/gutjnl-2014–306931
28. Lionetti E., Castellaneta S., Francavilla R., et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371:1295–303. DOI:10.1056/NEJMoa1400697
29. Vriezinga S.L., Auricchio R., Bravi E., et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014;371:1304–15. DOI:10.1056/NEJMoa1404172
30. Cellier, C., Grosdidier E. Refractory sprue, coeliac disease, and enteropathy- associated T-cell lymphoma. Lancet. 2000;356:203–208. DOI:10.1016/S0140–6736(00)02481–8
31. Rowinski S.A., Christensen E. Epidemiologic and therapeutic aspects of refractory coeliac disease–a systematic review. Dan Med J. 2016;63(12): A5307.
32. Eigner W., Bashir K., Primas C., et al. Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years. Aliment Pharmacol Ther. 2017;45: 364–372. DOI:10.1111/apt.13867
33. Mesova A.M., Sanbaev D. M. [Differential diagnosis of diseases associated with gluten intolerance (literature review)]. KazNMU Bulletin. 2016; 3: 10–15. (In Russ.)
34. Ierardi E., Giusepp L., Piscitelli D., et al. Seronegative celiac disease: Where is the specific setting? Gastroenterology and Hepatology From Bed to Bench. 2015; 8:110–116.
35. Krums LM, Parfenov AI, Sabelnikova EA, et al. [Sero negative celiac disease: A case report]. Ter Arkh. 2016;88(2):75–77. (In Russ.) doi: 10.17116/terarkh201688275–77
36. Aziz I., Ki T., Goodwin J. G., Sanders D. S. Predictors of celiac disease in cases of intraepithelial duodenal lymphocytosis in adults. J. Clin. Gastroenterologist. 2015;49: 477–482. DOI: 10.1097/MCG.0000000000000184
37. Brown I., Bettington M., Rosty C. The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions. Histopathology. 2021;78;1:88–105. Doi: 10.1111/his.14262
38. Fuchs V., Kurppa K., Huhtala H., et al. Serology- based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities. Aliment Pharmacol Ther. 2019;49: 277–284. DOI: 10.1111/apt.15109
39. Volta U., Caio G., Boschetti E., et al. Seronegative celiac disease: shedding light on an obscure clinical entity. Dig Liver Dis. 2016;48:1018–22. DOI: 10.1016/j.dld.2016.05.024
40. Oberhüber G., Granditsch G., Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94. DOI: 10.1097/00042737–199910000–00019
41. Corazza G.R., Villanacci V. Coeliac disease: some considerations on the histological diagnosis. J Clin Pathol. 2005;58:573–4.
42. Catassi C., Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123:691–693. DOI:10.1016/j.amjmed.2010.02.019
43. Rashtak S ., Ettore M. W., Homburger H. A ., Murray J. A. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2008;6:426–432. DOI: 10.1016/j.cgh.2007.12.030
44. Zakharova I.N., Borovik T. E., Roslavtseva E. A., Kasatkina E. N., Dmitrieva Yu.A. [Genetic markers of celiac disease: modern concepts]. Pediatr. 2014;5(2): 19–24. (In Russ.)
45. West J., Logan R. F., Card T. R., et al. Risk of vascular disease in adults with diagnosed coeliac disease: a population- based study. Aliment Pharmacol Ther. 2004;20:73–79. DOI:10.1111/j.1365–2036.2004.02008.x
46. Midhagen G., Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol. 2003;98.:2023–6. DOI: 10.1111/j.1572–0241.2003.07632.x
47. De Angelis M., Rizzelli C. G., Fasano A. et al. M.50. VSL#3 probiotic preparation has the capacity to hidrolyze gliadin polypeptides responsible for Celiac Sprue. Biochim. Biophys. Acta. 2006;1762(1):80–93.
48. Di Sabatino A, Corazza GR. Epitope- specific immunotherapy: a vaccine for coeliac disease? Lancet Gastroenterol Hepatol. 2017 Jul;2(7):464–465. DOI: 10.1016/S2468–1253(17)30141–3
49. Sitkin S.I., Avalueva E. B., Oreshko L. S., Khavkin A. I. Intestinal microbiota and dysbiosis in celiac disease. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2021;66(2):116– 122. (In Russ.) DOI: 10.21508/1027–4065–2021–66–2–116–122
50. Sitkin SI, Vakhitov TYa, Tkachenko EI, et al. Gut microbiota in ulcerative colitis and celiac disease. Eksp Klin Gastroenterol. 2017;(1):8–30. (In Russ.)
51. Sitkin S.I., Vakhitov T. Ya., Tkachenko E. I., et al. Dysbiosis in ulcerative colitis and celiac disease and its therapeutic correction by butyric acid plus inulin. Eksp Klin Gastroenterol. 2017;(6):77–98. (In Russ.)
Review
For citations:
Oreshko L.S., Bakulin I.G., Avalueva E.B., Semenova E.A., Sitkin S.I. Modern understanding of adult celiac disease. Experimental and Clinical Gastroenterology. 2021;(4):84-95. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-188-4-84-95
Views:
652
Email this article 